Multiparticulate Cannabinoid Formulations for Precise Immediate Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cannabinoid delivery methods, such as smoking and existing oral formulations, suffer from inefficiencies in absorption, erratic effects, and adverse side effects, with a need for a precise, uniform, and convenient dosage form for THC and CBD administration.

Innovation Solution

Development of multiparticulate solid oral dosage forms comprising cannabinoids in particles with uniform loading, which can be formulated for immediate release and targeted pharmacokinetics, available in tablets, capsules, or stick packs, using intra-granular excipients and porous bead cores for controlled delivery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If smoking is used to administer cannabinoids, then rapid absorption occurs, but harmful effects on lungs and erratic dosing occur

Engineering Contradiction:
Improveabsorption rateVSAvoidlung damage and erratic effects
Core Design Contradiction:
SpeedVSObject-affected harmful factors

Solution Approach 1:

The invention divides the single-dose smoking approach into multiple discrete particles (30-1500 μm) that can be uniformly distributed and swallowed, maintaining rapid absorption while eliminating lung damage. The multiparticulate system segments the cannabinoid delivery into controlled individual units.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention introduces an intermediary gastrointestinal delivery system that replaces direct lung absorption with controlled intestinal absorption. The particles serve as intermediaries that carry cannabinoids through the GI tract to achieve systemic delivery without lung exposure.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If oral formulations are used to avoid lung damage, then safety improves, but absorption efficiency and uniformity decrease

Engineering Contradiction:
Improvelung damage avoidanceVSAvoiddosage uniformity
Core Design Contradiction:
Object-affected harmful factorsVSManufacturing precision

Solution Approach 1:

The invention applies local quality by creating particles with specific size ranges (30-1500 μm) optimized for GI tract behavior. Different particle sizes can be tailored for different release characteristics, ensuring uniform distribution and absorption in the gastrointestinal system while maintaining safety.

Inventive Principle:
Principle #3Local quality

3Ease of operation

If conventional oral formulations are used, then administration convenience improves, but dosing precision and uniform distribution decrease

Engineering Contradiction:
Improveadministration convenienceVSAvoiddosing accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The invention segments the dosage into multiple uniform particles that can be easily administered as a complete unit (capsule, tablet, or sprinkle). This segmentation ensures each particle contains a precise amount of cannabinoid, guaranteeing dosing accuracy while maintaining ease of administration.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention achieves homogeneity by ensuring uniform cannabinoid distribution throughout all particles. Each particle is formulated with consistent composition and size, guaranteeing that the entire dosage provides uniform therapeutic effect regardless of how the particles are distributed in the GI tract.

Inventive Principle:
Principle #33Homogeneity

Data Source

PatentUS12350371B2Immediate release formulations of cannabinoids
Publication Date: 2025.07.08 GLATT GMBH
  • US12350371B2 patent drawing
  • US12350371B2 patent drawing
  • US12350371B2 patent drawing

AI summary

Compositions for the immediate release of one or more cannabinoids, in which the compositions comprise a population of particles. Each particle may comprise the one or more cannabinoids and one or more intra-granule excipients. Alternatively, each particle may comprise the one or more cannabinoids and a porous bead core. The composition may be prepared by a method that involves combining the one or more cannabinoids with the one or more intra-granule excipients, and then granulating the combination, such as through fluid bed granulation, shear-induced wet granulation, or spray granulation. The composition may also be prepared by a method that involves mixing the one or more cannabinoids with a population of porous bead cores.